Transcription of PRODUCT MONOGRAPH - GSK
{{id}} {{{paragraph}}}
Example: bachelor of science
PRODUCT MONOGRAPH - GSK
PRODUCT MONOGRAPH . PRIORIX. Combined measles , mumps and rubella vaccine , live, attenuated Lyophilized powder for injection Meets WHO requirements Active immunizing agent against infection by measles , mumps and rubella GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4. Date of Revision: August 14, 2019. Submission Control No: 228243.. 2019 GSK group of companies or its licensor Trademarks are owned by or licensed to the GSK group of companies. Page 1 of 23. Table of Contents PART I: HEALTH PROFESSIONAL 3. SUMMARY PRODUCT INFORMATION .. 3. 3. INDICATIONS AND CLINICAL 3. CONTRAINDICATIONS .. 4. WARNINGS AND 4. ADVERSE 7. DRUG INTERACTIONS .. 10. DOSAGE AND ADMINISTRATION .. 11. OVERDOSAGE .. 14. ACTION AND CLINICAL PHARMACOLOGY .. 14. STORAGE AND 14. DOSAGE FORMS, COMPOSITION AND PACKAGING .. 15. PART II: SCIENTIFIC INFORMATION .. 16. PHARMACEUTICAL 16.
Aug 12, 2019 · Transmission of measles and mumps virus from vaccinees to susceptible contacts has not been documented. Pharyngeal excretion of the rubella virus is known to occur approximately 7 to 28 days after vaccination, with peak excretion around the 11th day. However there is no evidence of transmission of this excreted vaccine virus to susceptible ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: